Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Andrén O[au]:

Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up. Bill-Axelson A et al. N Engl J Med. (2018)

Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Stopsack KH et al. Carcinogenesis. (2017)

Radical prostatectomy or watchful waiting in early prostate cancer. Bill-Axelson A et al. N Engl J Med. (2014)

Search results

Items: 1 to 50 of 97

1.

Degradable dendritic nanogels as carriers for antimicrobial peptides.

Nordström R, Andrén OCJ, Singh S, Malkoch M, Davoudi M, Schmidtchen A, Malmsten M.

J Colloid Interface Sci. 2019 Oct 15;554:592-602. doi: 10.1016/j.jcis.2019.07.028. Epub 2019 Jul 13.

PMID:
31330426
2.

Circulating inflammation markers and prostate cancer.

Ugge H, Downer MK, Carlsson J, Bowden M, Davidsson S, Mucci LA, Fall K, Andersson SO, Andrén O.

Prostate. 2019 Aug;79(11):1338-1346. doi: 10.1002/pros.23842. Epub 2019 Jun 18.

PMID:
31212389
3.

TRIM24 as an independent prognostic biomarker for prostate cancer.

Offermann A, Roth D, Hupe MC, Hohensteiner S, Becker F, Joerg V, Carlsson J, Kuempers C, Ribbat-Idel J, Tharun L, Sailer V, Kirfel J, Svensson M, Andren O, Lubczyk V, Kuefer R, Merseburger AS, Perner S.

Urol Oncol. 2019 Sep;37(9):576.e1-576.e10. doi: 10.1016/j.urolonc.2019.05.006. Epub 2019 Jun 7.

PMID:
31178279
4.

Penetration and Accumulation of Dendrons with Different Peripheral Composition in Pseudomonas aeruginosa Biofilms.

Rozenbaum RT, Andrén OCJ, van der Mei HC, Woudstra W, Busscher HJ, Malkoch M, Sharma PK.

Nano Lett. 2019 Jul 10;19(7):4327-4333. doi: 10.1021/acs.nanolett.9b00838. Epub 2019 Jun 7.

5.

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.

Jerlström T, Chen R, Liedberg F, Andrén O, Ströck V, Aljabery FAS, Hosseini A, Sherif A, Malmström PU, Ullén A, Gårdmark T, Fall K.

World J Urol. 2019 Apr 24. doi: 10.1007/s00345-019-02770-2. [Epub ahead of print]

PMID:
31020424
6.

PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes.

Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O.

Eur Urol Oncol. 2019 Mar;2(2):214-221. doi: 10.1016/j.euo.2018.07.010. Epub 2018 Aug 23.

PMID:
31017099
7.

Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.

Zelic R, Zugna D, Bottai M, Andrén O, Fridfeldt J, Carlsson J, Davidsson S, Fiano V, Fiorentino M, Giunchi F, Grasso C, Lianas L, Mascia C, Molinaro L, Zanetti G, Richiardi L, Pettersson A, Akre O.

Am J Epidemiol. 2019 Jun 1;188(6):1165-1173. doi: 10.1093/aje/kwz026.

PMID:
30976789
8.

The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS).

Bratt O, Holmberg E, Andrén O, Carlsson S, Drevin L, Johansson E, Josefsson A, Nyberg M, Sandberg J, Stattin P, Robinsson D.

Eur Urol. 2019 Oct;76(4):461-466. doi: 10.1016/j.eururo.2019.02.035. Epub 2019 Mar 14.

PMID:
30878303
9.

Antibiotic-Free Cationic Dendritic Hydrogels as Surgical-Site-Infection-Inhibiting Coatings.

Andrén OCJ, Ingverud T, Hult D, Håkansson J, Bogestål Y, Caous JS, Blom K, Zhang Y, Andersson T, Pedersen E, Björn C, Löwenhielm P, Malkoch M.

Adv Healthc Mater. 2019 Mar;8(5):e1801619. doi: 10.1002/adhm.201801619. Epub 2019 Feb 8.

PMID:
30735288
10.

Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.

Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Andrén O, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801.

PMID:
30575473
11.

Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies.

Carlsson J, Davidsson S, Fridfeldt J, Giunchi F, Fiano V, Grasso C, Zelic R, Richiardi L, Andrén O, Pettersson A, Fiorentino M, Akre O.

BMC Med Res Methodol. 2018 Dec 5;18(1):161. doi: 10.1186/s12874-018-0628-1.

12.

M2 macrophages and regulatory T cells in lethal prostate cancer.

Erlandsson A, Carlsson J, Lundholm M, Fält A, Andersson SO, Andrén O, Davidsson S.

Prostate. 2019 Mar;79(4):363-369. doi: 10.1002/pros.23742. Epub 2018 Nov 30.

13.

Appendicitis before Age 20 Years Is Associated with an Increased Risk of Later Prostate Cancer.

Ugge H, Udumyan R, Carlsson J, Davidsson S, Andrén O, Montgomery S, Fall K.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):660-664. doi: 10.1158/1055-9965.EPI-17-1204. Epub 2018 Mar 27.

14.

The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells.

Mushtaq M, Jensen L, Davidsson S, Grygoruk OV, Andrén O, Kashuba V, Kashuba E.

Sci Rep. 2018 Feb 2;8(1):2268. doi: 10.1038/s41598-018-20765-8.

15.

High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer.

Erlandsson A, Carlsson J, Andersson SO, Vyas C, Wikström P, Andrén O, Davidsson S, Rider JR.

Scand J Urol. 2018 Apr;52(2):129-133. doi: 10.1080/21681805.2017.1421261. Epub 2018 Jan 8.

PMID:
29307261
16.

Acne in late adolescence and risk of prostate cancer.

Ugge H, Udumyan R, Carlsson J, Andrén O, Montgomery S, Davidsson S, Fall K.

Int J Cancer. 2018 Apr 15;142(8):1580-1585. doi: 10.1002/ijc.31192. Epub 2017 Dec 14.

17.

Prevalence of Flp Pili-Encoding Plasmids in Cutibacterium acnes Isolates Obtained from Prostatic Tissue.

Davidsson S, Carlsson J, Mölling P, Gashi N, Andrén O, Andersson SO, Brzuszkiewicz E, Poehlein A, Al-Zeer MA, Brinkmann V, Scavenius C, Nazipi S, Söderquist B, Brüggemann H.

Front Microbiol. 2017 Nov 16;8:2241. doi: 10.3389/fmicb.2017.02241. eCollection 2017.

18.

Membrane interactions of microgels as carriers of antimicrobial peptides.

Nordström R, Nyström L, Andrén OCJ, Malkoch M, Umerska A, Davoudi M, Schmidtchen A, Malmsten M.

J Colloid Interface Sci. 2018 Mar 1;513:141-150. doi: 10.1016/j.jcis.2017.11.014. Epub 2017 Nov 6.

PMID:
29145017
19.

Synthesis and in Vitro Evaluation of Monodisperse Amino-Functional Polyester Dendrimers with Rapid Degradability and Antibacterial Properties.

Stenström P, Hjorth E, Zhang Y, Andrén OCJ, Guette-Marquet S, Schultzberg M, Malkoch M.

Biomacromolecules. 2017 Dec 11;18(12):4323-4330. doi: 10.1021/acs.biomac.7b01364. Epub 2017 Nov 22.

PMID:
29131611
20.

Heterogeneous Rupturing Dendrimers.

Andrén OCJ, Fernandes AP, Malkoch M.

J Am Chem Soc. 2017 Dec 6;139(48):17660-17666. doi: 10.1021/jacs.7b10377. Epub 2017 Nov 22.

PMID:
29125743
21.

FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer.

Davidsson S, Andren O, Ohlson AL, Carlsson J, Andersson SO, Giunchi F, Rider JR, Fiorentino M.

Prostate. 2018 Jan;78(1):40-47. doi: 10.1002/pros.23442. Epub 2017 Nov 6.

22.

Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease.

Lu D, Carlsson J, Penney KL, Davidsson S, Andersson SO, Mucci LA, Valdimarsdóttir U, Andrén O, Fang F, Fall K.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1781-1787. doi: 10.1158/1055-9965.EPI-17-0453. Epub 2017 Sep 22.

23.

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.

Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson SO, Watson RW, Pennington S, Finn SP, Martin NE, Stampfer MJ, Parmigiani G, Penney KL, Fiorentino M, Mucci LA, Loda M.

Nat Commun. 2017 Sep 4;8(1):420. doi: 10.1038/s41467-017-00460-4.

24.

A Walking Intervention Among Men With Prostate Cancer: A Pilot Study.

Pernar CH, Fall K, Rider JR, Markt SC, Adami HO, Andersson SO, Valdimarsdottir U, Andrén O, Mucci LA.

Clin Genitourin Cancer. 2017 Dec;15(6):e1021-e1028. doi: 10.1016/j.clgc.2017.05.022. Epub 2017 May 31.

25.

Cholesterol uptake and regulation in high-grade and lethal prostate cancers.

Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA, Rider JR.

Carcinogenesis. 2017 Aug 1;38(8):806-811. doi: 10.1093/carcin/bgx058.

26.

Dairy intake in relation to prostate cancer survival.

Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO.

Int J Cancer. 2017 May 1;140(9):2060-2069. doi: 10.1002/ijc.30642. Epub 2017 Feb 22.

27.

Perineural Invasion and Risk of Lethal Prostate Cancer.

Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):719-726. doi: 10.1158/1055-9965.EPI-16-0237. Epub 2017 Jan 6.

28.

Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies.

Ali I, Julin B, Glynn A, Högberg J, Berglund M, Johansson JE, Andersson SO, Andrén O, Giovannucci E, Wolk A, Stenius U, Åkesson A.

Carcinogenesis. 2016 Dec;37(12):1144-1151. Epub 2016 Oct 7.

PMID:
27742691
29.

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.

Brägelmann J, Klümper N, Offermann A, von Mässenhausen A, Böhm D, Deng M, Queisser A, Sanders C, Syring I, Merseburger AS, Vogel W, Sievers E, Vlasic I, Carlsson J, Andrén O, Brossart P, Duensing S, Svensson MA, Shaikhibrahim Z, Kirfel J, Perner S.

Clin Cancer Res. 2017 Apr 1;23(7):1829-1840. doi: 10.1158/1078-0432.CCR-16-0094. Epub 2016 Sep 27.

30.

Erratum to: Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer.

Davidsson S, Mölling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, Andersson SO, Elgh F, Söderquist B, Andrén O.

Infect Agent Cancer. 2016 Jun 21;11:36. doi: 10.1186/s13027-016-0084-7. eCollection 2016.

31.

Cholesterol Metabolism and Prostate Cancer Lethality.

Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR.

Cancer Res. 2016 Aug 15;76(16):4785-90. doi: 10.1158/0008-5472.CAN-16-0903. Epub 2016 Jun 20.

32.

Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer.

Davidsson S, Mölling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, Andersson SO, Elgh F, Söderquis B, Andrén O.

Infect Agent Cancer. 2016 Jun 9;11:26. doi: 10.1186/s13027-016-0074-9. eCollection 2016. Erratum in: Infect Agent Cancer. 2016;11:36.

33.

IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2.

Merz C, von Mässenhausen A, Queisser A, Vogel W, Andrén O, Kirfel J, Duensing S, Perner S, Nowak M.

Am J Pathol. 2016 Apr;186(4):974-84. doi: 10.1016/j.ajpath.2015.12.009.

PMID:
27012192
34.

Fluoride-Promoted Esterification (FPE) Chemistry: A Robust Route to Bis-MPA Dendrons and Their Postfunctionalization.

Stenström P, Andrén OC, Malkoch M.

Molecules. 2016 Mar 17;21(3):366. doi: 10.3390/molecules21030366.

35.

Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.

Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2016 Mar;37(3):262-8. doi: 10.1093/carcin/bgw001. Epub 2016 Jan 16.

36.

The Proteome of Primary Prostate Cancer.

Iglesias-Gato D, Wikström P, Tyanova S, Lavallee C, Thysell E, Carlsson J, Hägglöf C, Cox J, Andrén O, Stattin P, Egevad L, Widmark A, Bjartell A, Collins CC, Bergh A, Geiger T, Mann M, Flores-Morales A.

Eur Urol. 2016 May;69(5):942-52. doi: 10.1016/j.eururo.2015.10.053. Epub 2015 Dec 2.

PMID:
26651926
37.

Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer.

Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M.

Mol Cancer Res. 2015 Oct;13(10):1431-40. doi: 10.1158/1541-7786.MCR-14-0569. Epub 2015 Jun 29.

38.

[Go for MRI in the diagnosis of prostate cancer].

Bratt O, Ahlgren G, Andrén O, Blomqvist L, Carlsson S, Damber JE, Hugosson J, Jäderling F, Karlsson CT, Robinson D.

Lakartidningen. 2015 Apr 20;112. pii: DFZ3. Swedish. No abstract available.

39.

Molecular differences in transition zone and peripheral zone prostate tumors.

Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, Sesso HD, Loda M, Fall K, Stampfer MJ, Mucci LA, Pawitan Y, Andersson SO, Andrén O.

Carcinogenesis. 2015 Jun;36(6):632-8. doi: 10.1093/carcin/bgv051. Epub 2015 Apr 13.

40.

Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy.

Persson B, Carringer M, Andrén O, Andersson SO, Carlsson J, Ljungqvist O.

Scand J Urol. 2015;49(4):302-7. doi: 10.3109/21681805.2015.1004641. Epub 2015 Feb 7.

PMID:
25660105
41.

Prognostic significance of YWHAZ expression in localized prostate cancer.

Rüenauver K, Menon R, Svensson MA, Carlsson J, Vogel W, Andrén O, Nowak M, Perner S.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):310-4. doi: 10.1038/pcan.2014.32. Epub 2014 Aug 26.

PMID:
25156059
42.

Limited evidence for the use of imaging to detect prostate cancer: a systematic review.

Blomqvist L, Carlsson S, Gjertsson P, Heintz E, Hultcrantz M, Mejare I, Andrén O.

Eur J Radiol. 2014 Sep;83(9):1601-6. doi: 10.1016/j.ejrad.2014.06.028. Epub 2014 Jul 5. Review.

PMID:
25059597
43.

Analysis of incidence and prognosis from 'extreme' case-control designs.

Salim A, Ma X, Fall K, Andrén O, Reilly M.

Stat Med. 2014 Dec 30;33(30):5388-98. doi: 10.1002/sim.6245. Epub 2014 Jul 1.

PMID:
24980445
44.

MED12 overexpression is a frequent event in castration-resistant prostate cancer.

Shaikhibrahim Z, Offermann A, Braun M, Menon R, Syring I, Nowak M, Halbach R, Vogel W, Ruiz C, Zellweger T, Rentsch CA, Svensson M, Andren O, Bubendorf L, Biskup S, Duensing S, Kirfel J, Perner S.

Endocr Relat Cancer. 2014 Aug;21(4):663-75. doi: 10.1530/ERC-14-0171. Epub 2014 Jun 17.

PMID:
24938407
45.

Radical prostatectomy or watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2014 Mar 6;370(10):932-42. doi: 10.1056/NEJMoa1311593.

46.
47.

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

Blattner M, Lee DJ, O'Reilly C, Park K, MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, Heguy A, Sboner A, Ramazangolu S, Hieronymus H, Sawyers C, Tewari AK, Moch H, Yoon GS, Known YC, Andrén O, Fall K, Demichelis F, Mosquera JM, Robinson BD, Barbieri CE, Rubin MA.

Neoplasia. 2014 Jan;16(1):14-20.

48.

A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohort.

Svensson MA, Perner S, Ohlson AL, Day JR, Groskopf J, Kirsten R, Sollie T, Helenius G, Andersson SO, Demichelis F, Andrén O, Rubin MA.

Appl Immunohistochem Mol Morphol. 2014;22(2):136-41. doi: 10.1097/PDM.0b013e31829e0484.

PMID:
24517914
49.

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.

Shaikhibrahim Z, Menon R, Braun M, Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C, Zellweger T, Svensson M, Andren O, Kristiansen G, Wernert N, Bubendorf L, Kirfel J, Biskup S, Perner S.

Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9.

50.

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.

Carlsson J, Helenius G, Karlsson MG, Andrén O, Klinga-Levan K, Olsson B.

BMC Cancer. 2013 Jul 29;13:362. doi: 10.1186/1471-2407-13-362.

Supplemental Content

Loading ...
Support Center